title: Inhaled surfactant in the treatment of accidental talc powder inhalation: a new case report.
abstract: The use of talcum powder is incorrectly part of the traditional care of infants. Its acute aspiration is a very dangerous condition in childhood. Although the use of baby powder has been discouraged from many authors and the reports of its accidental inhalation have been ever more rare, sometimes new cases with several fatalities have been reported. We report on a patient in which accidental inhalation of baby powder induced severe respiratory difficulties. We also point out the benefits of surfactant administration. Surfactant contributed to the rapid improvement of the medical and radiological condition, preventing severe early and late complications and avoiding invasive approaches.
authors.affiliation: Clinica Pediatrica, Dipartimento Universitario Materno-Infantile, Università degli Studi di Palermo, Via Alfonso Giordano, 3. Palermo, 90143, Italy. fedematina@libero.it
authors.forename: Federico
authors.initials: F
authors.lastname: Matina
authors.forename: Mirella
authors.initials: M
authors.lastname: Collura
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Maggio
authors.forename: Patrizio
authors.initials: P
authors.lastname: Vitulo
authors.forename: Caterina
authors.initials: C
authors.lastname: Lo Piparo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Corsello
mesh_terms: D000280:Administration, Inhalation; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001688:Biological Products / Q000008:administration & dosage / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003371:Cough / Q000188:drug therapy / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008171:Lung Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology*; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use*; D011208:Powders / Q000009:adverse effects*; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000627:therapeutic use*; D011859:Radiography; D013627:Talc / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D001688:Biological Products; D001993:Bronchodilator Agents; D010743:Phospholipids; D011208:Powders; D011663:Pulmonary Surfactants; D013627:Talc; C068291:poractant alfa